大结直肠转移瘤(≥50mm)的腹腔镜保留肝实质切除
该研究分析1999-2019年奥斯陆大学医院587例因结直肠肝转移行腹腔镜保留肝实质切除(少于连续3个肝段)的患者,比较≥50mm大肿瘤(59例)与<50mm小肿瘤(528例)的手术与肿瘤学结局。大肿瘤组5年总生存率较低(34% vs 49%,p=0.027),但多变量Cox回归显示肿瘤大小不影响生存,而年龄、ASA评分、CEA水平、肝手术时肝外疾病和原发肿瘤淋巴结阳性是独立因素。结论认为腹腔镜保留肝实质切除治疗大结直肠肝转移可获得满意的短期和长期结局。
要点
- 大肿瘤组中位肿瘤60mm(范围50-110),小肿瘤组21mm(3-48)。
- 大肿瘤组中位出血量更高(500ml vs 200ml,p<0.001),手术时间和中转率相似。
- 多变量分析中肿瘤大小不影响生存,而年龄、ASA评分、CEA等是危险因素。
核心结论
- 腹腔镜保留肝实质切除治疗大结直肠肝转移可获得满意的短期和长期结局。
- 多变量Cox回归显示肿瘤大小不影响生存,而年龄、ASA评分、CEA水平、肝手术时肝外疾病和原发肿瘤淋巴结阳性是生存影响因素。
研究设计与样本
- 回顾性分析1999-2019年奥斯陆大学医院587例因结直肠肝转移主要行腹腔镜保留肝实质切除(少于连续3个肝段)的患者。
- 比较≥50mm大肿瘤组(n=59)与<50mm小肿瘤组(n=528)的手术和肿瘤学结局,并行多变量Cox回归分析。
主要发现
- 大肿瘤组中位肿瘤大小60mm(范围50-110),小肿瘤组21mm(3-48),p<0.001。
- 大肿瘤组年龄和CEA水平更高(CEA 8.4 μg/L vs 4.6 μg/L,p<0.001)。
- 手术时间和中转率相似,大肿瘤组中位出血量更高(500ml vs 200ml,p<0.001)。
- 大肿瘤组5年总生存率更低(34% vs 49%,p=0.027)。
临床怎么用
- 对于大结直肠肝转移(≥50mm),腹腔镜保留肝实质切除是可行选择,但需注意出血量可能增加。
- 肿瘤大小本身不影响生存,应综合评估年龄、ASA评分、CEA水平、肝外疾病和原发肿瘤淋巴结状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Traditionally, patients with large liver tumors (≥ 50 mm) have been considered for anatomic major hepatectomy. Laparoscopic resection of large liver lesions is technically challenging and often performed by surgeons with extensive experience. The current study aimed to evaluate the surgical and oncologic safety of laparoscopic parenchyma-sparing liver resection in patients with large colorectal metastases. METHODS: Patients who primarily underwent laparoscopic parenchyma-sparing liver resection (less than 3 consecutive liver segments) for colorectal liver metastases between 1999 and 2019 at Oslo University Hospital were analyzed. In some recent cases, a computer-assisted surgical planning system was used to better visualize and understand the patients' liver anatomy, as well as a tool to further improve the resection strategy. The surgical and oncologic outcomes of patients with large (≥ 50 mm) and small (< 50 mm) tumors were compared. Multivariable Cox-regression analysis was performed to identify risk factors for survival. RESULTS: In total 587 patients met the inclusion criteria (large tumor group, n = 59; and small tumor group, n = 528). Median tumor size was 60 mm (range, 50-110) in the large tumor group and 21 mm (3-48) in the small tumor group (p < 0.001). Patient age and CEA level were higher in the large tumor group (8.4 μg/L vs. 4.6 μg/L, p < 0.001). Operation time and conversion rate were similar, while median blood loss was higher in the large tumor group (500 ml vs. 200 ml, p < 0.001). Patients in the large tumor group had shorter 5 year overall survival (34% vs 49%, p = 0.027). However, in the multivariable Cox-regression analysis tumor size did not impact survival, unlike parameters such as age, ASA score, CEA level, extrahepatic disease at liver surgery, and positive lymph nodes in the primary tumor. CONCLUSION: Laparoscopic parenchyma-sparing resections for large colorectal liver metastases provide satisfactory short and long-term outcomes.
引用
- Aghayan DL, d'Albenzio G, Fretland ÅA, et al. Laparoscopic parenchyma-sparing liver resection for large (≥ 50 mm) colorectal metastases. Surg Endosc. 2022. PMID: 35922606. doi:10.1007/s00464-022-09493-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。